Abstract
Background: Peritoneal dialysis-associated peritonitis (PD-peritonitis) due to Mycobacterium spp is uncommon. Non-tuberculous Mycobacterium (NTB) PD-peritonitis can present in a similar fashion to more common causes of bacterial PD-peritonitis. We describe the first reported case of multiresistant Mycobacterium fortuitum PD-peritonitis in an Australian patient. Case presentation: A 38 year-old woman developed mild PD-peritonitis during an overseas holiday. Treatment was complicated by delayed diagnosis, requirement for special investigations, treatment with multiple antibiotics, and conversion to haemodialysis following removal of her Tenckhoff catheter. Conclusion: This case demonstrates the diagnostic yield of pursuing further investigations in cases of initially culture-negative, problematic PD-peritonitis. A systematic review of the literature identified only 17 reports of M. fortuitum PD-peritonitis. Similar to our case, a delay in microbiological diagnosis was frequently noted and the Tenckhoff catheter was commonly removed at the time of diagnosis. The type and duration of antibiotic therapy also varied widely so the optimum treatment appears to be poorly defined.
Original language | English |
---|---|
Article number | 35 |
Number of pages | 5 |
Journal | BMC Nephrology |
Volume | 13 |
Issue number | 1 |
DOIs | |
Publication status | Published - 2012 |
Open Access - Access Right Statement
© 2012 Jiang et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Keywords
- Australia
- amikacin
- antibiotic therapy
- hemodialysis
- linezolid
- moxifloxacin
- mycobacteriosis
- mycobacterium fortuitum
- nausea
- peritoneal dialysis
- peritonitis
- sulfamethoxazole
- trimethoprim
- vancomycin